GGrantIndex
Sort

78,016 grants matching breast cancer

Beyond Binding: Personalized Multi-omic Neoantigen Identification

$657,934
Rachel Karchin · Johns Hopkins University · R01 · FY2025 · CA

Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)

$657,837
Debra L Friedman · Vanderbilt University Medical Center · R01 · FY2021 · CA

Imputation-based approach to identify low frequency variants in prostate cancer

$657,827
Fredrick Ray Schumacher · University Of Southern California · U01 · FY2014 · CA

Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition

$657,821
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2018 · CA

Phenotypic marker-guided development of selective antimetastasis therapeutic leads

$657,810
Sui Huang · Northwestern University At Chicago · R01 · FY2022 · CA

Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition

$657,802
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2017 · CA

Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer

$657,801
Neil Mukund Iyengar · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Improving Patient Outcomes Through System Navigation

$657,693
Peter C Raich · Denver Health And Hospital Authority · U01 · FY2009 · CA

OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System

$657,655
Hoda J. Badr · Baylor College Of Medicine · R01 · FY2021 · CA

Project 1: Chromosome Inheritance

$657,623
Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2021 · CA

Project 1: Chromosome Inheritance

$657,623
Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2020 · CA

Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes

$657,621
Patrick J O'Connor · Healthpartners Institute · R01 · FY2024 · CA

Randomized controlled trial of FoRtitude: Targeted eHealth intervention to reduce fear of recurrence among breast cancer survivors in community oncology settings

$657,618
Lynne I. Wagner · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA

Stromal contributions to breast carcinogenesis

$657,613
Lusine Yaghjyan · University Of Florida · R01 · FY2024 · CA

Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials

$657,592
Sandi Leigh Pruitt · Ut Southwestern Medical Center · R01 · FY2021 · CA

Biological Studies

$657,482
John Quackenbush · Harvard School Of Public Health · U19 · FY2011 · CA

Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications

$657,412
Mark David Pagel · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer

$657,403
Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2024 · CA

Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE)

$657,319
Jun J Mao · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors

$657,316
Qian Lu · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Remodeling the Immune Landscape in Breast Cancer Leptomeningeal Disease Using Dendritic Cell Therapy is an Effective Treatment and Protects Against Disease Recurrence.

$657,121
Peter Alexander Forsyth · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

Harmonization of breast MRI data

$657,101
Maciej A. Mazurowski · Duke University · R01 · FY2022 · EB

Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment

$657,074
Lan Zhou · Methodist Hospital Research Institute · R01 · FY2025 · CA

Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines

$657,066
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Clinical trials employing cancer vaccine combination therapies

$657,066
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA